BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 10329546)

  • 1. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
    Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
    Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.
    Darteil R; Bublot M; Laplace E; Bouquet JF; Audonnet JC; Rivière M
    Virology; 1995 Aug; 211(2):481-90. PubMed ID: 7645252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus.
    Tsukamoto K; Sato T; Saito S; Tanimura N; Hamazaki N; Mase M; Yamaguchi S
    Virology; 2000 Apr; 269(2):257-67. PubMed ID: 10753704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
    Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens.
    Mahmood MS; Hussain I; Siddique M; Akhtar M; Ali S
    Vaccine; 2007 Nov; 25(44):7629-35. PubMed ID: 17913306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide.
    Mahmood MS; Siddique M; Hussain I; Khan A; Mansoor MK
    Vaccine; 2006 May; 24(22):4838-46. PubMed ID: 16600440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies.
    Li K; Liu Y; Zhang Y; Gao L; Liu C; Cui H; Qi X; Gao Y; Zhong L; Wang X
    Vet Immunol Immunopathol; 2017 Apr; 186():55-59. PubMed ID: 28413051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and immunological characterization of recombinant Marek's disease virus expressing IBDV VP2 fusion protein].
    Liu HM; Qin AJ; Liu YL; Jin WJ; Ye JQ; Chen HJ; Shao HX; Li YX
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):391-6. PubMed ID: 16755916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
    Sharma JM
    Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody titers to infectious bursal disease virus in broiler chicks after vaccination at one day of age with infectious bursal disease virus and Marek's disease virus.
    Knoblich HV; Sommer SE; Jackwood DJ
    Avian Dis; 2000; 44(4):874-84. PubMed ID: 11195642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines.
    Kim SJ; Sung HW; Han JH; Jackwood D; Kwon HM
    Vet Microbiol; 2004 Jun; 101(1):39-51. PubMed ID: 15201032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-mediated vaccination conferring protection against infectious bursal disease in broiler chickens in the presence of maternal antibody.
    Hsieh MK; Wu CC; Lin TL
    Vaccine; 2010 May; 28(23):3936-43. PubMed ID: 20394722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of three live vaccines against highly virulent infectious bursal disease virus in chickens with or without maternal antibodies.
    Tsukamoto K; Tanimura N; Kakita S; Ota K; Mase M; Imai K; Hihara H
    Avian Dis; 1995; 39(2):218-29. PubMed ID: 7677642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.